Loading...
NPI 1760460430 · Staten Island, NY · Specialist
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Joel Sherman is a specialist provider located in Staten Island, New York. This profile covers 45 Medicare and 7 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Joel Sherman |
| Address | 4143 Hylan Blvd |
| City | Staten Island |
| State | NY |
| ZIP | 10308 |
| Taxonomy | Specialist |
| NPI Enumerated | January 4, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1M |
| Medicaid | $2.7K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
45 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,200 | $80 | $169.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,160 | $110 | $128.6K |
| 88120 | The lab analyst performs a technical lab test on a urinary tract specimen using in situ hybridization and three to five molecular probes for manual morphometric analysis, looking at the number and… | 420 | $280 | $116.1K |
| 52224 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 70 | $750 | $53.4K |
| J0897 | Injection, denosumab, 1 mg | 2,520 | $20 | $47.9K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 1,160 | $40 | $45.2K |
| 88112 | Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in… | 1,170 | $30 | $35.1K |
| 51792 | This procedure measures the electrical activity in the anal or urethral sphincter muscles. | 130 | $260 | $34.6K |
| 76770 | A retroperitoneal ultrasound is a noninvasive procedure used to assess the body parts within the abdomen (i.e.Kidneys, urinary bladder, and aorta). This particular code is used when the ultrasound is… | 370 | $90 | $34.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 260 | $130 | $33.4K |
Showing 1–10 of 45
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 45 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
45 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 88120 | 4 | 30 | 90 | $450 | $133.6K |
| J0897 | 265 | 490 | 2,820 | $20 | $84.4K |
| 88305 | 680 | 980 | 370 | $50 | $58.5K |
| 52224 | 4 | 40 | 20 | $680 | $25K |
| 51792 | 6 | 20 | 110 | $230 | $23.2K |
| 52648 | 12 | 30 | 20 | $940 | $21.5K |
| 52214 | 7 | 20 | 20 | $670 | $19.4K |
| 99214 | 517 | 30,450 | 90 | $100 | $19K |
| J9217 | 16 | 160 | 110 | $130 | $18.1K |
| 51728 | 30 | 170 | 30 | $310 | $16K |
Showing 1–10 of 45
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 330 | $10 | $2.3K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 150 | $1 | $450 |
| 1036F | N/A | 240 | $0 | $0 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 10 | $0 | $0 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 230 | $0 | $0 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 80 | $0 | $0 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 240 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
7 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 9,814 | 19,110 | 360 | $70 | $321K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 160 | 300 | 190 | $20 | $16.8K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 971 | 2,000 | 210 | $1 | $90 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 188 | 450 | 150 | $1 | $50 |
| 1036F | N/A | 748 | 1,770 | 150 | $1 | $50 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 1,096 | 1,160 | 300 | $1 | $30 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 63 | 110 | 100 | $1 | $10 |
Other providers in the same ZIP code as Joel Sherman, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Interscience Diagnostic Laboratories,inc | NY | Clinical Medical Laboratory | $1.2M | $5.4M |
| Aliza Skaya | NY | Clinical Social Worker | $327.7K | $77.1K |
| Tatyana Katsman | NY | Family Medicine Physician | $86.5K | $89.6K |
| Lisa Hernandez | NY | Internal Medicine Physician | $120.7K | $0 |
| Igor Brichkov | NY | Vascular Surgery Physician | $56.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.